This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
MS Bauer , L Mitchner (2004). What is a ‘mood stabilizer’? An evidence-based response. American Journal of Psychiatry 161, 3–18.
FM Besag , GY Ng , F Pool (2000). Successful re-introduction of lamotrigine after initial rash. Seizure 9, 282–286.
JM Bostwick , VS Pankratz (2000). Affective disorders and suicide risk: a reexamination. American Journal of Psychiatry 157, 1925–1932.
CL Bowden , JR Calabrese , G Sachs , LN Yatham , SA Asghar , M Hompland , P Montgomery , N Earl , TM Smoot , J DeVeaugh-Geiss (2003). A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Archives of General Psychiatry 60, 392–400.
CL Bowden , P Mitchell , T Suppes (1999). Lamotrigine in the treatment of bipolar depression. European Neuropsychopharmacology 9 (Suppl. 4), S113–117.
MJ Brodie , PW Overstall , L Giorgi (1999). Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy. The UK Lamotrigine Elderly Study Group. Epilepsy Research 37, 81–87.
MJ Brodie , A Richens , AW Yuen (1995). Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. UK Lamotrigine/Carbamazepine Monotherapy Trial Group. Lancet 345, 476–479.
RD Buzan , SL Dubovsky (1998). Recurrence of lamotrigine-associated rash with rechallenge. Journal of Clinical Psychiatry 59, 87.
JR Calabrese , CL Bowden , G Sachs , LN Yatham , K Behnke , OP Mehtonen , P Montgomery , J Ascher , W Paska , N Earl , J DeVeaugh-Geiss (2003). A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. Journal of Clinical Psychiatry 64, 1013–1024.
JR Calabrese , CL Bowden , GS Sachs , JA Ascher , E Monaghan , GD Rudd (1999). A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group. Journal of Clinical Psychiatry 60, 79–88.
JR Calabrese , JR Sullivan , CL Bowden , T Suppes , JF Goldberg , GS Sachs , MD Shelton , FK Goodwin , MA Frye , V Kusumakar (2002). Rash in multicenter trials of lamotrigine in mood disorders: clinical relevance and management. Journal of Clinical Psychiatry 63, 1012–1019.
D Chisholm , M van Ommeren , JL Ayuso-Mateos , S Saxena (2005). Cost-effectiveness of clinical interventions for reducing the global burden of bipolar disorder. British Journal of Psychiatry 187, 559–567.
JT Coyle , DS Pine , DS Charney , L Lewis , CB Nemeroff , GA Carlson , PT Joshi , D Reiss , RD Todd , M Hellander (2003). Depression and bipolar support alliance consensus statement on the unmet needs in diagnosis and treatment of mood disorders in children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry 42, 1494–1503.
P Eames (1989). Adverse reactions to carbamazepine managed by desensitisation. Lancet 1, 509–510.
MA Frye , MJ Gitlin , LL Altshuler (2004). Unmet needs in bipolar depression. Depression and Anxiety 19, 199–208.
P Gelisse , A Crespel (2006). Reintroduction of treatment with lamotrigine in combination with valproate after an initial allergic skin reaction [in French]. Revue Neurologique 162, 1122–1124.
SN Ghaemi (2008). Treatment of rapid-cycling bipolar disorder: are antidepressants mood destabilizers? American Journal of Psychiatry 165, 300–302.
SN Ghaemi , M Bauer , F Cassidy , GS Malhi , P Mitchell , J Phelps , E Vieta , E Youngstrom (2008). Diagnostic guidelines for bipolar disorder: a summary of the International Society for Bipolar Disorders Diagnostic Guidelines Task Force Report. Bipolar Disorders 10, 117–128.
GM Goodwin , CL Bowden , JR Calabrese , H Grunze , S Kasper , R White , P Greene , R Leadbetter (2004). A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder. Journal of Clinical Psychiatry 65, 432–441.
LL Judd , HS Akiskal , PJ Schettler , J Endicott , J Maser , DA Solomon , AC Leon , JA Rice , MB Keller (2002). The long-term natural history of the weekly symptomatic status of bipolar I disorder. Archives of General Psychiatry 59, 530–537.
S Karande , NJ Gogtay , S Kanchan , NA Kshirsagar (2006). Anticonvulsant hypersensitivity syndrome to lamotrigine confirmed by lymphocyte stimulation in vitro. Indian Journal of Medical Sciences 60, 59–63.
S Kaur , R Sarkar , GP Thami , AJ Kanwar (2002). Anticonvulsant hypersensitivity syndrome. Pediatric Dermatology 19, 142–145.
TA Ketter , JH Greist , JA Graham , JN Roberts , TR Thompson , KP Nanry (2006). The effect of dermatologic precautions on the incidence of rash with addition of lamotrigine in the treatment of bipolar I disorder: a randomized trial. Journal of Clinical Psychiatry 67, 400–406.
G Manfredi , I Pacchiarotti , GD Kotzalidis , A Ruberto , P Girardi , R Tatarelli (2004). Successful rechallenge with slowly titrated lamotrigine after rash. Bipolar Disorders 6, 338–339.
M Mockenhaupt , J Messenheimer , P Tennis , J Schlingmann (2005). Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptics. Neurology 64, 1134–1138.
Tigaran S P-Codrea , P Sidenius , M Dam (2005). Lamotrigine-induced rash – worth a rechallenge. Acta Neurologica Scandinavica 111, 191–194.
RM Post , LL Altshuler , MA Frye , T Suppes , SL McElroy , PE Keck Jr., GS Leverich , R Kupka , WA Nolen , DA Luckenbaugh , J Walden , H Grunze (2005). Preliminary observations on the effectiveness of levetiracetam in the open adjunctive treatment of refractory bipolar disorder. Journal of Clinical Psychiatry 66, 370–374.
RM Post , GS Leverich , WA Nolen , RW Kupka , LL Altshuler , MA Frye , T Suppes , S McElroy , P Keck , H Grunze , J Walden (2003). A re-evaluation of the role of antidepressants in the treatment of bipolar depression: data from the Stanley Foundation Bipolar Network. Bipolar Disorders 5, 396–406.
RF Prien , CJ Klett , EM Caffey Jr. (1973). Lithium carbonate and imipramine in prevention of affective episodes. A comparison in recurrent affective illness. Archives of General Psychiatry 29, 420–425.
JC Roujeau (2005). Clinical heterogeneity of drug hypersensitivity. Toxicology 209, 123–129.
GS Sachs (2003). Unmet clinical needs in bipolar disorder. Journal of Clinical Psychopharmacolology 23 (Suppl. 1), S2–8.
GS Sachs , AA Nierenberg , JR Calabrese , LB Marangell , SR Wisniewski , L Gyulai , ES Friedman , CL Bowden , MD Fossey , MJ Ostacher , (2007). Effectiveness of adjunctive antidepressant treatment for bipolar depression. New England Journal of Medicine 356, 1711–1722.
B Sadock , V Sadock (2005). Kaplan and Sadock's Comprehensive Textbook of Psychiatry. Philadelphia: Lippincott Williams and Wilkins.
T Steiner , L Findley , A Yuen (1997). Lamotrigine versus placebo in the prophylaxis of migraine with and without aura. Cephalalgia 17, 109–112.
SJ Tavernor , IC Wong , R Newton , SW Brown (1995). Rechallenge with lamotrigine after initial rash. Seizure 4, 67–71.
CC Vittorio , JJ Muglia (1995). Anticonvulsant hypersensitivity syndrome. Archives of Internal Medicine 155, 2285–2290.
JK Warnock , DW Morris (2003). Adverse cutaneous reactions to mood stabilizers. American Journal of Clinical Dermatology 4, 21–30.
TA Wehr , FK Goodwin (1979). Rapid cycling in manic-depressives induced by tricyclic antidepressants. Archives of General Psychiatry 36, 555–559.
R Wolf , B Davidovici , H Matz , K Mahlab , E Orion , ZM Sthoeger (2006). Drug rash with eosinophilia and systemic symptoms versus Stevens–Johnson Syndrome – a case that indicates a stumbling block in the current classification. International Archives of Allergy and Immunology 141, 308–310.